Ramesh Ramakrishnan, Senior Vice President, R&D at Talis Biomedical Corp (TLIS), bought 1,000 shares at $16.00 ($16K) on 2021-02-17, disclosed to the SEC on 2021-02-19.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.